Ipamorelin vs GHRP-6
A detailed comparison to help you understand the differences and choose the right peptide for your research.
Ipamorelin and GHRP-6 are both Growth Hormone Releasing Peptides, but they differ significantly in their selectivity and side effect profiles. GHRP-6 was one of the first GHRPs developed and produces robust GH release along with significant hunger stimulation. Ipamorelin was developed later with improved selectivity, producing GH release without the hunger spike.
Quick Comparison
Key Similarities
- Both are GHRPs that stimulate GH release from the pituitary
- Both work by mimicking ghrelin at the GHSR receptor
- Both use similar dosing protocols (2-3x daily)
- Both work synergistically with GHRH peptides
- Both should be taken on an empty stomach
- Both produce pulsatile GH release
Key Differences
- GHRP-6 causes intense hunger; Ipamorelin does not
- GHRP-6 raises cortisol and prolactin; Ipamorelin doesn't
- GHRP-6 may produce slightly stronger GH release
- Ipamorelin is more selective with a cleaner profile
- GHRP-6 is better for those wanting to increase appetite
- Ipamorelin is better for cutting phases
When to Choose Each
Choose Ipamorelin
Choose Ipamorelin when you want GH stimulation without the hunger increase, cortisol elevation, or other hormonal effects. It's the preferred choice during cutting phases or for those who want the 'cleanest' GHRP experience.
Choose GHRP-6
Choose GHRP-6 when maximum GH release is the priority and increased appetite is either desired or acceptable. It's popular for bulking phases when the hunger spike can help with caloric intake.
Can You Stack Them?
Both can be combined with GHRH peptides like CJC-1295 or Sermorelin for synergistic GH release. Some even combine Ipamorelin and GHRP-6 together, using lower doses of GHRP-6 to get some appetite stimulation while keeping Ipamorelin as the primary GHRP.
Frequently Asked Questions
References
- Bowers CY. "Comparison of GHRPs." J Clin Endocrinol Metab, 1998. PMID: 9768674
- Raun K, et al. "Ipamorelin selectivity profile." Eur J Endocrinol, 1998. PMID: 9758455
Get the Complete Comparison Guide
Download our detailed comparison charts and decision framework.